cdmo.directory
← Compare landing

Enable Biotech Ltd vs Omniabio

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/enablebiotech/omniabio

CategoryEnable Biotech LtdOmniabio
Listed sitecdmocdmo
SummaryEnable Biotech provides clinical GMP manufacturing for cell therapies, exosome therapies, and gene therapies, with SwissMedic accreditation pending for gene therapy operations as of summer 2024.OmniaBio is a cell and gene therapy CDMO specializing in process development, analytical development, and GMP manufacturing for lentiviral vectors, iPSCs, and immune cell-based therapies. The company operates a 120,000 sq ft facility in Hamilton, Ontario, integrating AI, automation, and robotics to deliver scalable manufacturing from preclinical to commercial stages.
Services
  • Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • Autologous Cell Therapy Manufacturing
  • CMC Regulatory Submission Support
  • Process Development
  • CMC Analytical Development
  • Cell-Line Development
  • Autologous Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • Cell Therapy Manufacturing
  • Lentiviral Vector Manufacturing
  • CMC Regulatory Submission Support
Modalities
  • Cell Therapy
  • Gene Therapy
  • Cell Therapy
  • Gene Therapy
IndicationsData not yet provided.Data not yet provided.
Locations
  • Headquarters, Zug, Switzerland
  • Headquarters & Manufacturing Facility, Hamilton, Ontario, Canada
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.